These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38428644)

  • 1. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease.
    Thorhauge KH; Semmler G; Johansen S; Lindvig KP; Kjærgaard M; Hansen JK; Torp N; Hansen CD; Andersen P; Hofer BS; Gu W; Israelsen M; Mandorfer M; Reiberger T; Trebicka J; Thiele M; Krag A;
    J Hepatol; 2024 Jul; 81(1):23-32. PubMed ID: 38428644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure.
    Semmler G; Alonso López S; Pons M; Lens S; Dajti E; Griemsmann M; Zanetto A; Burghart L; Hametner-Schreil S; Hartl L; Manzano M; Rodriguez-Tajes S; Zanaga P; Schwarz M; Gutierrez ML; Jachs M; Pocurull A; Polo B; Ecker D; Mateos B; Izquierdo S; Real Y; Ahumada A; Bauer DJM; Mauz JB; Casanova-Cabral M; Gschwantler M; Russo FP; Azzaroli F; Maasoumy B; Reiberger T; Forns X; Genesca J; Bañares R; Mandorfer M;
    J Hepatol; 2024 Jul; 81(1):76-83. PubMed ID: 38521170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta.
    Jachs M; Sandmann L; Hartl L; Tergast T; Schwarz M; Bauer DJM; Balcar L; Ehrenbauer A; Hofer BS; Cornberg M; Lenzen H; Deterding K; Trauner M; Mandorfer M; Wedemeyer H; Reiberger T; Maasoumy B
    J Hepatol; 2024 Aug; 81(2):248-257. PubMed ID: 38479612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD.
    Gawrieh S; Vilar-Gomez E; Wilson LA; Pike F; Kleiner DE; Neuschwander-Tetri BA; Diehl AM; Dasarathy S; Kowdley KV; Hameed B; Tonascia J; Loomba R; Sanyal AJ; Chalasani N;
    J Hepatol; 2024 Oct; 81(4):600-608. PubMed ID: 38762169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.
    Papatheodoridi M; Hiriart JB; Lupsor-Platon M; Bronte F; Boursier J; Elshaarawy O; Marra F; Thiele M; Markakis G; Payance A; Brodkin E; Castera L; Papatheodoridis G; Krag A; Arena U; Mueller S; Cales P; Calvaruso V; de Ledinghen V; Pinzani M; Tsochatzis EA
    J Hepatol; 2021 May; 74(5):1109-1116. PubMed ID: 33307138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease.
    Semmler G; Yang Z; Fritz L; Köck F; Hofer BS; Balcar L; Hartl L; Jachs M; Stopfer K; Schedlbauer A; Neumayer D; Maurer J; Müllner-Bucsics T; Simbrunner B; Scheiner B; Trauner M; Mandorfer M; Reiberger T; Bauer DJM
    Gastroenterology; 2023 Oct; 165(4):1041-1052. PubMed ID: 37442301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.
    Pons M; Rodríguez-Tajes S; Esteban JI; Mariño Z; Vargas V; Lens S; Buti M; Augustin S; Forns X; Mínguez B; Genescà J
    J Hepatol; 2020 Mar; 72(3):472-480. PubMed ID: 31629779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHESS-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: An international multicenter study.
    Wong YJ; Li J; Liu C; Chen Z; Chan YH; Putera M; Teh KB; Ang TL; Zhao L; Yan Z; Kumar R; Li X; Qi X
    J Gastroenterol Hepatol; 2022 Jun; 37(6):1043-1051. PubMed ID: 35253271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease.
    Zhou XD; Kim SU; Yip TC; Petta S; Nakajima A; Tsochatzis E; Boursier J; Bugianesi E; Hagström H; Chan WK; Romero-Gomez M; Calleja JL; de Lédinghen V; Castéra L; Sanyal AJ; Goh GB; Newsome PN; Fan J; Lai M; Fournier-Poizat C; Lee HW; Wong GL; Armandi A; Shang Y; Pennisi G; Llop E; Yoneda M; Saint-Loup M; Canivet CM; Lara-Romero C; Gallego-Duràn R; Asgharpour A; Teh KK; Mahgoub S; Chan MS; Lin H; Liu WY; Targher G; Byrne CD; Wong VW; Zheng MH;
    Gut; 2024 Oct; 73(11):1883-1892. PubMed ID: 39089860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compensated Advanced Chronic Liver Disease in Nonalcoholic Fatty Liver Disease: Two-Step Strategy is Better than Baveno Criteria.
    Elhence A; Anand A; Biswas S; Vaishnav M; Yadav R; Das P; Panwar R; Agarwal S; Gamanagatti S; Kumar R; Shalimar
    Dig Dis Sci; 2023 Mar; 68(3):1016-1025. PubMed ID: 35670897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease.
    Pons M; Simón-Talero M; Millán L; Ventura-Cots M; Santos B; Augustin S; Genescà J
    Dig Liver Dis; 2016 Oct; 48(10):1214-9. PubMed ID: 27388262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Pons M; Augustin S; Scheiner B; Guillaume M; Rosselli M; Rodrigues SG; Stefanescu H; Ma MM; Mandorfer M; Mergeay-Fabre M; Procopet B; Schwabl P; Ferlitsch A; Semmler G; Berzigotti A; Tsochatzis E; Bureau C; Reiberger T; Bosch J; Abraldes JG; Genescà J
    Am J Gastroenterol; 2021 Apr; 116(4):723-732. PubMed ID: 33982942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms.
    Papatheodoridi M; De Ledinghen V; Lupsor-Platon M; Bronte F; Boursier J; Elshaarawy O; Marra F; Thiele M; Markakis G; Payance A; Brodkin E; Castera L; Papatheodoridis G; Krag A; Arena U; Mueller S; Cales P; Calvaruso V; Delamarre A; Pinzani M; Tsochatzis EA
    J Hepatol; 2024 Oct; 81(4):590-599. PubMed ID: 38789011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
    Petta S; Sebastiani G; Viganò M; Ampuero J; Wai-Sun Wong V; Boursier J; Berzigotti A; Bugianesi E; Fracanzani AL; Cammà C; Enea M; Grottes MD; Di Marco V; Younes R; Keyrouz A; Mazzola S; Mendoza Y; Pennisi G; Romero-Gomez M; Craxì A; de Ledinghen V
    Clin Gastroenterol Hepatol; 2021 Apr; 19(4):806-815.e5. PubMed ID: 32621970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis.
    Rigamonti C; Cittone MG; Manfredi GF; De Benedittis C; Paggi N; Baorda F; Di Benedetto D; Minisini R; Pirisi M
    JHEP Rep; 2024 Jan; 6(1):100952. PubMed ID: 38192539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive tests for clinically significant portal hypertension after HCV cure.
    Semmler G; Lens S; Meyer EL; Baiges A; Alvardo-Tapias E; Llop E; Tellez L; Schwabl P; Mauro E; Escudé L; Díez C; Ibañez-Samaniego L; Puente Á; Fortea JI; Abadía M; Zanetto A; Conthe A; Hernandez-Évole H; Luzko Scheid IS; Jia J; Yoshiji H; Francque SM; Tsochatzis EA; Russo FP; Crespo G; Forns X; Bañares R; Villanueva C; Hernández-Gea V; Reiberger T; Bosch J; García Pagán JC; Mandorfer M;
    J Hepatol; 2022 Dec; 77(6):1573-1585. PubMed ID: 36063968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease.
    Scheiner B; Steininger L; Semmler G; Unger LW; Schwabl P; Bucsics T; Paternostro R; Ferlitsch A; Trauner M; Reiberger T; Mandorfer M
    Liver Int; 2019 Jan; 39(1):127-135. PubMed ID: 30107095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient.
    Jachs M; Hartl L; Simbrunner B; Semmler G; Balcar L; Hofer BS; Schwarz M; Bauer D; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
    J Hepatol; 2024 May; 80(5):744-752. PubMed ID: 38218352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of dynamic changes in liver stiffness measurement in patients with chronic hepatitis B and compensated advanced chronic liver disease.
    Yu H; Huang Y; Li M; Jiang H; Yang B; Xi X; Smayi A; Wu B; Yang Y
    J Gastroenterol Hepatol; 2024 Oct; 39(10):2169-2181. PubMed ID: 38946401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria.
    Jindal A; Sharma S; Agarwal S; Kumar M; Saraya A; Sarin SK
    Hepatol Int; 2022 Feb; 16(1):89-98. PubMed ID: 35072932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.